These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38739849)

  • 1. Estimating hepatitis C prevalence in the United States, 2017-2020.
    Hall EW; Bradley H; Barker LK; Lewis KC; Shealey J; Valverde E; Sullivan P; Gupta N; Hofmeister MG
    Hepatology; 2024 May; ():. PubMed ID: 38739849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016.
    Rosenberg ES; Rosenthal EM; Hall EW; Barker L; Hofmeister MG; Sullivan PS; Dietz P; Mermin J; Ryerson AB
    JAMA Netw Open; 2018 Dec; 1(8):e186371. PubMed ID: 30646319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.
    Hofmeister MG; Rosenthal EM; Barker LK; Rosenberg ES; Barranco MA; Hall EW; Edlin BR; Mermin J; Ward JW; Ryerson AB
    Hepatology; 2019 Mar; 69(3):1020-1031. PubMed ID: 30398671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Rosenberg ES; Hall EW; Sullivan PS; Sanchez TH; Workowski KA; Ward JW; Holtzman D
    Clin Infect Dis; 2017 Jun; 64(11):1573-1581. PubMed ID: 28449115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.
    Denniston MM; Jiles RB; Drobeniuc J; Klevens RM; Ward JW; McQuillan GM; Holmberg SD
    Ann Intern Med; 2014 Mar; 160(5):293-300. PubMed ID: 24737271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010.
    Hall EW; Rosenberg ES; Sullivan PS
    BMC Infect Dis; 2018 May; 18(1):224. PubMed ID: 29769036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.
    Lewis KC; Barker LK; Jiles RB; Gupta N
    Clin Infect Dis; 2023 Nov; 77(10):1413-1415. PubMed ID: 37417196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.
    Lansky A; Finlayson T; Johnson C; Holtzman D; Wejnert C; Mitsch A; Gust D; Chen R; Mizuno Y; Crepaz N
    PLoS One; 2014; 9(5):e97596. PubMed ID: 24840662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities-National HIV Behavioral Surveillance, 2018.
    Chapin-Bardales J; Asher A; Broz D; Teshale E; Mixson-Hayden T; Poe A; Handanagic S; Blanco C; Wejnert C;
    Int J Drug Policy; 2024 Mar; ():104387. PubMed ID: 38531730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
    Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
    Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.
    Buchanan R; Khakoo SI; Coad J; Grellier L; Parkes J
    Harm Reduct J; 2017 Jul; 14(1):44. PubMed ID: 28697760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
    Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.
    Ditah I; Ditah F; Devaki P; Ewelukwa O; Ditah C; Njei B; Luma HN; Charlton M
    J Hepatol; 2014 Apr; 60(4):691-8. PubMed ID: 24291324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
    Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
    Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.